Pharma & Healthcare
Global Andrographis Paniculana Injection Market Research Report 2026
- Feb 03, 26
- ID: 697581
- Pages: 132
- Figures: 128
- Views: 5
This report delivers a comprehensive overview of the global Andrographis Paniculana Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Andrographis Paniculana Injection. The Andrographis Paniculana Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Andrographis Paniculana Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Andrographis Paniculana Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Langzhi Group Wanrong Pharmaceutical Co., Ltd.
Shanxi Huawei Pharmaceutical Co., Ltd.
Zhengda Qingchunbao Pharmaceutical Co., Ltd.
Changchun Dazheng Pharmaceutical Technology Co., Ltd.
Henan Kanghua Pharmaceutical Co., Ltd.
Hainan Pharmaceutical Factory Co., Ltd.
Guangdong Leiyunshang Pharmaceutical Co., Ltd.
Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
Lizhu Group Limin Pharmaceutical Factory
Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Jiangxi Yuankang Judu Pharmaceutical Co., Ltd.
Shenwei Pharmaceutical (Sichuan) Co., Ltd.
Shanxi Kangyi Pharmaceutical Co., Ltd.
Jiangsu Hengfeng Pharmaceutical Co., Ltd.
Guangdong Luofushan National Pharmaceutical Co., Ltd.
Guangdong Xinfeng Pharmaceutical Co., Ltd.
Segment by Type
2ml
5ml
10ml
Others
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Andrographis Paniculana Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Andrographis Paniculana Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Andrographis Paniculana Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Andrographis Paniculana Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Langzhi Group Wanrong Pharmaceutical Co., Ltd.
Shanxi Huawei Pharmaceutical Co., Ltd.
Zhengda Qingchunbao Pharmaceutical Co., Ltd.
Changchun Dazheng Pharmaceutical Technology Co., Ltd.
Henan Kanghua Pharmaceutical Co., Ltd.
Hainan Pharmaceutical Factory Co., Ltd.
Guangdong Leiyunshang Pharmaceutical Co., Ltd.
Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
Lizhu Group Limin Pharmaceutical Factory
Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Jiangxi Yuankang Judu Pharmaceutical Co., Ltd.
Shenwei Pharmaceutical (Sichuan) Co., Ltd.
Shanxi Kangyi Pharmaceutical Co., Ltd.
Jiangsu Hengfeng Pharmaceutical Co., Ltd.
Guangdong Luofushan National Pharmaceutical Co., Ltd.
Guangdong Xinfeng Pharmaceutical Co., Ltd.
Segment by Type
2ml
5ml
10ml
Others
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Andrographis Paniculana Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Andrographis Paniculana Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Andrographis Paniculana Injection Market Overview
1.1 Product Definition
1.2 Andrographis Paniculana Injection by Type
1.2.1 Global Andrographis Paniculana Injection Market Value by Type: 2025 vs 2032
1.2.2 2ml
1.2.3 5ml
1.2.4 10ml
1.2.5 Others
1.3 Andrographis Paniculana Injection by Application
1.3.1 Global Andrographis Paniculana Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Andrographis Paniculana Injection Market Size Estimates and Forecasts
1.4.1 Global Andrographis Paniculana Injection Revenue 2021–2032
1.4.2 Global Andrographis Paniculana Injection Sales 2021–2032
1.4.3 Global Andrographis Paniculana Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Andrographis Paniculana Injection Market Competition by Manufacturers
2.1 Global Andrographis Paniculana Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Andrographis Paniculana Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Andrographis Paniculana Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Andrographis Paniculana Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Andrographis Paniculana Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Andrographis Paniculana Injection, Product Types and Applications
2.7 Global Key Manufacturers of Andrographis Paniculana Injection, Date of Entry into the Industry
2.8 Global Andrographis Paniculana Injection Market Competitive Situation and Trends
2.8.1 Global Andrographis Paniculana Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Andrographis Paniculana Injection Players Market Share by Revenue
2.8.3 Global Andrographis Paniculana Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographis Paniculana Injection Market Scenario by Region
3.1 Global Andrographis Paniculana Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Andrographis Paniculana Injection Sales by Region: 2021–2032
3.2.1 Global Andrographis Paniculana Injection Sales by Region: 2021–2026
3.2.2 Global Andrographis Paniculana Injection Sales by Region: 2027–2032
3.3 Global Andrographis Paniculana Injection Revenue by Region: 2021–2032
3.3.1 Global Andrographis Paniculana Injection Revenue by Region: 2021–2026
3.3.2 Global Andrographis Paniculana Injection Revenue by Region: 2027–2032
3.4 North America Andrographis Paniculana Injection Market Facts & Figures by Country
3.4.1 North America Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Andrographis Paniculana Injection Sales by Country (2021–2032)
3.4.3 North America Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographis Paniculana Injection Market Facts & Figures by Country
3.5.1 Europe Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Andrographis Paniculana Injection Sales by Country (2021–2032)
3.5.3 Europe Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographis Paniculana Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographis Paniculana Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Andrographis Paniculana Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Andrographis Paniculana Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographis Paniculana Injection Market Facts & Figures by Country
3.7.1 Latin America Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Andrographis Paniculana Injection Sales by Country (2021–2032)
3.7.3 Latin America Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographis Paniculana Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Andrographis Paniculana Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographis Paniculana Injection Sales by Type (2021–2032)
4.1.1 Global Andrographis Paniculana Injection Sales by Type (2021–2026)
4.1.2 Global Andrographis Paniculana Injection Sales by Type (2027–2032)
4.1.3 Global Andrographis Paniculana Injection Sales Market Share by Type (2021–2032)
4.2 Global Andrographis Paniculana Injection Revenue by Type (2021–2032)
4.2.1 Global Andrographis Paniculana Injection Revenue by Type (2021–2026)
4.2.2 Global Andrographis Paniculana Injection Revenue by Type (2027–2032)
4.2.3 Global Andrographis Paniculana Injection Revenue Market Share by Type (2021–2032)
4.3 Global Andrographis Paniculana Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Andrographis Paniculana Injection Sales by Application (2021–2032)
5.1.1 Global Andrographis Paniculana Injection Sales by Application (2021–2026)
5.1.2 Global Andrographis Paniculana Injection Sales by Application (2027–2032)
5.1.3 Global Andrographis Paniculana Injection Sales Market Share by Application (2021–2032)
5.2 Global Andrographis Paniculana Injection Revenue by Application (2021–2032)
5.2.1 Global Andrographis Paniculana Injection Revenue by Application (2021–2026)
5.2.2 Global Andrographis Paniculana Injection Revenue by Application (2027–2032)
5.2.3 Global Andrographis Paniculana Injection Revenue Market Share by Application (2021–2032)
5.3 Global Andrographis Paniculana Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd.
6.1.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
6.1.2 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.1.5 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shanxi Huawei Pharmaceutical Co., Ltd.
6.2.1 Shanxi Huawei Pharmaceutical Co., Ltd. Company Information
6.2.2 Shanxi Huawei Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.2.5 Shanxi Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Zhengda Qingchunbao Pharmaceutical Co., Ltd.
6.3.1 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Company Information
6.3.2 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.3.5 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Changchun Dazheng Pharmaceutical Technology Co., Ltd.
6.4.1 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Company Information
6.4.2 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.4.3 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.4.5 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.5 Henan Kanghua Pharmaceutical Co., Ltd.
6.5.1 Henan Kanghua Pharmaceutical Co., Ltd. Company Information
6.5.2 Henan Kanghua Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.5.5 Henan Kanghua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Hainan Pharmaceutical Factory Co., Ltd.
6.6.1 Hainan Pharmaceutical Factory Co., Ltd. Company Information
6.6.2 Hainan Pharmaceutical Factory Co., Ltd. Description and Business Overview
6.6.3 Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.6.5 Hainan Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
6.7 Guangdong Leiyunshang Pharmaceutical Co., Ltd.
6.7.1 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
6.7.2 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.7.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
6.8.1 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information
6.8.2 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.8.5 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
6.9.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
6.9.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.9.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Lizhu Group Limin Pharmaceutical Factory
6.10.1 Lizhu Group Limin Pharmaceutical Factory Company Information
6.10.2 Lizhu Group Limin Pharmaceutical Factory Description and Business Overview
6.10.3 Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Product Portfolio
6.10.5 Lizhu Group Limin Pharmaceutical Factory Recent Developments/Updates
6.11 Jiangsu Kangyuan Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Company Information
6.11.2 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.11.5 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd.
6.12.1 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Company Information
6.12.2 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.12.5 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Shenwei Pharmaceutical (Sichuan) Co., Ltd.
6.13.1 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Company Information
6.13.2 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Description and Business Overview
6.13.3 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.13.5 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Recent Developments/Updates
6.14 Shanxi Kangyi Pharmaceutical Co., Ltd.
6.14.1 Shanxi Kangyi Pharmaceutical Co., Ltd. Company Information
6.14.2 Shanxi Kangyi Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.14.5 Shanxi Kangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Jiangsu Hengfeng Pharmaceutical Co., Ltd.
6.15.1 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Company Information
6.15.2 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.15.5 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Guangdong Luofushan National Pharmaceutical Co., Ltd.
6.16.1 Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information
6.16.2 Guangdong Luofushan National Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.16.5 Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Guangdong Xinfeng Pharmaceutical Co., Ltd.
6.17.1 Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
6.17.2 Guangdong Xinfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.17.5 Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographis Paniculana Injection Industry Chain Analysis
7.2 Andrographis Paniculana Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographis Paniculana Injection Production Mode & Process Analysis
7.4 Andrographis Paniculana Injection Sales and Marketing
7.4.1 Andrographis Paniculana Injection Sales Channels
7.4.2 Andrographis Paniculana Injection Distributors
7.5 Andrographis Paniculana Injection Customer Analysis
8 Andrographis Paniculana Injection Market Dynamics
8.1 Andrographis Paniculana Injection Industry Trends
8.2 Andrographis Paniculana Injection Market Drivers
8.3 Andrographis Paniculana Injection Market Challenges
8.4 Andrographis Paniculana Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Andrographis Paniculana Injection by Type
1.2.1 Global Andrographis Paniculana Injection Market Value by Type: 2025 vs 2032
1.2.2 2ml
1.2.3 5ml
1.2.4 10ml
1.2.5 Others
1.3 Andrographis Paniculana Injection by Application
1.3.1 Global Andrographis Paniculana Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Andrographis Paniculana Injection Market Size Estimates and Forecasts
1.4.1 Global Andrographis Paniculana Injection Revenue 2021–2032
1.4.2 Global Andrographis Paniculana Injection Sales 2021–2032
1.4.3 Global Andrographis Paniculana Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Andrographis Paniculana Injection Market Competition by Manufacturers
2.1 Global Andrographis Paniculana Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Andrographis Paniculana Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Andrographis Paniculana Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Andrographis Paniculana Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Andrographis Paniculana Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Andrographis Paniculana Injection, Product Types and Applications
2.7 Global Key Manufacturers of Andrographis Paniculana Injection, Date of Entry into the Industry
2.8 Global Andrographis Paniculana Injection Market Competitive Situation and Trends
2.8.1 Global Andrographis Paniculana Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Andrographis Paniculana Injection Players Market Share by Revenue
2.8.3 Global Andrographis Paniculana Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographis Paniculana Injection Market Scenario by Region
3.1 Global Andrographis Paniculana Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Andrographis Paniculana Injection Sales by Region: 2021–2032
3.2.1 Global Andrographis Paniculana Injection Sales by Region: 2021–2026
3.2.2 Global Andrographis Paniculana Injection Sales by Region: 2027–2032
3.3 Global Andrographis Paniculana Injection Revenue by Region: 2021–2032
3.3.1 Global Andrographis Paniculana Injection Revenue by Region: 2021–2026
3.3.2 Global Andrographis Paniculana Injection Revenue by Region: 2027–2032
3.4 North America Andrographis Paniculana Injection Market Facts & Figures by Country
3.4.1 North America Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Andrographis Paniculana Injection Sales by Country (2021–2032)
3.4.3 North America Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographis Paniculana Injection Market Facts & Figures by Country
3.5.1 Europe Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Andrographis Paniculana Injection Sales by Country (2021–2032)
3.5.3 Europe Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographis Paniculana Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographis Paniculana Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Andrographis Paniculana Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Andrographis Paniculana Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographis Paniculana Injection Market Facts & Figures by Country
3.7.1 Latin America Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Andrographis Paniculana Injection Sales by Country (2021–2032)
3.7.3 Latin America Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographis Paniculana Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographis Paniculana Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Andrographis Paniculana Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Andrographis Paniculana Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographis Paniculana Injection Sales by Type (2021–2032)
4.1.1 Global Andrographis Paniculana Injection Sales by Type (2021–2026)
4.1.2 Global Andrographis Paniculana Injection Sales by Type (2027–2032)
4.1.3 Global Andrographis Paniculana Injection Sales Market Share by Type (2021–2032)
4.2 Global Andrographis Paniculana Injection Revenue by Type (2021–2032)
4.2.1 Global Andrographis Paniculana Injection Revenue by Type (2021–2026)
4.2.2 Global Andrographis Paniculana Injection Revenue by Type (2027–2032)
4.2.3 Global Andrographis Paniculana Injection Revenue Market Share by Type (2021–2032)
4.3 Global Andrographis Paniculana Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Andrographis Paniculana Injection Sales by Application (2021–2032)
5.1.1 Global Andrographis Paniculana Injection Sales by Application (2021–2026)
5.1.2 Global Andrographis Paniculana Injection Sales by Application (2027–2032)
5.1.3 Global Andrographis Paniculana Injection Sales Market Share by Application (2021–2032)
5.2 Global Andrographis Paniculana Injection Revenue by Application (2021–2032)
5.2.1 Global Andrographis Paniculana Injection Revenue by Application (2021–2026)
5.2.2 Global Andrographis Paniculana Injection Revenue by Application (2027–2032)
5.2.3 Global Andrographis Paniculana Injection Revenue Market Share by Application (2021–2032)
5.3 Global Andrographis Paniculana Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd.
6.1.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
6.1.2 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.1.5 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shanxi Huawei Pharmaceutical Co., Ltd.
6.2.1 Shanxi Huawei Pharmaceutical Co., Ltd. Company Information
6.2.2 Shanxi Huawei Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.2.5 Shanxi Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Zhengda Qingchunbao Pharmaceutical Co., Ltd.
6.3.1 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Company Information
6.3.2 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.3.5 Zhengda Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Changchun Dazheng Pharmaceutical Technology Co., Ltd.
6.4.1 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Company Information
6.4.2 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.4.3 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.4.5 Changchun Dazheng Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.5 Henan Kanghua Pharmaceutical Co., Ltd.
6.5.1 Henan Kanghua Pharmaceutical Co., Ltd. Company Information
6.5.2 Henan Kanghua Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.5.5 Henan Kanghua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Hainan Pharmaceutical Factory Co., Ltd.
6.6.1 Hainan Pharmaceutical Factory Co., Ltd. Company Information
6.6.2 Hainan Pharmaceutical Factory Co., Ltd. Description and Business Overview
6.6.3 Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.6.5 Hainan Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
6.7 Guangdong Leiyunshang Pharmaceutical Co., Ltd.
6.7.1 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
6.7.2 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.7.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
6.8.1 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information
6.8.2 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.8.5 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
6.9.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
6.9.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.9.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Lizhu Group Limin Pharmaceutical Factory
6.10.1 Lizhu Group Limin Pharmaceutical Factory Company Information
6.10.2 Lizhu Group Limin Pharmaceutical Factory Description and Business Overview
6.10.3 Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Product Portfolio
6.10.5 Lizhu Group Limin Pharmaceutical Factory Recent Developments/Updates
6.11 Jiangsu Kangyuan Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Company Information
6.11.2 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.11.5 Jiangsu Kangyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd.
6.12.1 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Company Information
6.12.2 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.12.5 Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Shenwei Pharmaceutical (Sichuan) Co., Ltd.
6.13.1 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Company Information
6.13.2 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Description and Business Overview
6.13.3 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.13.5 Shenwei Pharmaceutical (Sichuan) Co., Ltd. Recent Developments/Updates
6.14 Shanxi Kangyi Pharmaceutical Co., Ltd.
6.14.1 Shanxi Kangyi Pharmaceutical Co., Ltd. Company Information
6.14.2 Shanxi Kangyi Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.14.5 Shanxi Kangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Jiangsu Hengfeng Pharmaceutical Co., Ltd.
6.15.1 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Company Information
6.15.2 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.15.5 Jiangsu Hengfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Guangdong Luofushan National Pharmaceutical Co., Ltd.
6.16.1 Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information
6.16.2 Guangdong Luofushan National Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.16.5 Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Guangdong Xinfeng Pharmaceutical Co., Ltd.
6.17.1 Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
6.17.2 Guangdong Xinfeng Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product Portfolio
6.17.5 Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographis Paniculana Injection Industry Chain Analysis
7.2 Andrographis Paniculana Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographis Paniculana Injection Production Mode & Process Analysis
7.4 Andrographis Paniculana Injection Sales and Marketing
7.4.1 Andrographis Paniculana Injection Sales Channels
7.4.2 Andrographis Paniculana Injection Distributors
7.5 Andrographis Paniculana Injection Customer Analysis
8 Andrographis Paniculana Injection Market Dynamics
8.1 Andrographis Paniculana Injection Industry Trends
8.2 Andrographis Paniculana Injection Market Drivers
8.3 Andrographis Paniculana Injection Market Challenges
8.4 Andrographis Paniculana Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Andrographis Paniculana Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Andrographis Paniculana Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Andrographis Paniculana Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Andrographis Paniculana Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Andrographis Paniculana Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Andrographis Paniculana Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Andrographis Paniculana Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Andrographis Paniculana Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Andrographis Paniculana Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Andrographis Paniculana Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Andrographis Paniculana Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Andrographis Paniculana Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographis Paniculana Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Andrographis Paniculana Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographis Paniculana Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Andrographis Paniculana Injection Sales by Region (K Units), 2021–2026
Table 18. Global Andrographis Paniculana Injection Sales Market Share by Region (2021–2026)
Table 19. Global Andrographis Paniculana Injection Sales by Region (K Units), 2027–2032
Table 20. Global Andrographis Paniculana Injection Sales Market Share by Region (2027–2032)
Table 21. Global Andrographis Paniculana Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Andrographis Paniculana Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Andrographis Paniculana Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Andrographis Paniculana Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 27. North America Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 28. North America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Andrographis Paniculana Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Andrographis Paniculana Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Andrographis Paniculana Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Andrographis Paniculana Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Andrographis Paniculana Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Andrographis Paniculana Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Andrographis Paniculana Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Andrographis Paniculana Injection Sales Market Share by Type (2021–2026)
Table 53. Global Andrographis Paniculana Injection Sales Market Share by Type (2027–2032)
Table 54. Global Andrographis Paniculana Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Andrographis Paniculana Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Andrographis Paniculana Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Andrographis Paniculana Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Andrographis Paniculana Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Andrographis Paniculana Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Andrographis Paniculana Injection Sales Market Share by Application (2021–2026)
Table 63. Global Andrographis Paniculana Injection Sales Market Share by Application (2027–2032)
Table 64. Global Andrographis Paniculana Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Andrographis Paniculana Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Andrographis Paniculana Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Andrographis Paniculana Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
Table 71. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 74. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Shanxi Huawei Pharmaceutical Co., Ltd. Company Information
Table 76. Shanxi Huawei Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 79. Shanxi Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Company Information
Table 81. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 84. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Company Information
Table 86. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Description and Business Overview
Table 87. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Product
Table 89. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
Table 90. Henan Kanghua Pharmaceutical Co., Ltd. Company Information
Table 91. Henan Kanghua Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 94. Henan Kanghua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Hainan Pharmaceutical Factory Co., Ltd. Company Information
Table 96. Hainan Pharmaceutical Factory Co., Ltd. Description and Business Overview
Table 97. Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Product
Table 99. Hainan Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 100. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
Table 101. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 104. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information
Table 106. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 109. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
Table 111. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 114. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Lizhu Group Limin Pharmaceutical Factory Company Information
Table 116. Lizhu Group Limin Pharmaceutical Factory Description and Business Overview
Table 117. Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Product
Table 119. Lizhu Group Limin Pharmaceutical Factory Recent Developments/Updates
Table 120. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Company Information
Table 121. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 124. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Company Information
Table 126. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 129. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Company Information
Table 131. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Description and Business Overview
Table 132. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Product
Table 134. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Recent Developments/Updates
Table 135. Shanxi Kangyi Pharmaceutical Co., Ltd. Company Information
Table 136. Shanxi Kangyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 137. Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 139. Shanxi Kangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 140. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Company Information
Table 141. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 144. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information
Table 146. Guangdong Luofushan National Pharmaceutical Co., Ltd. Description and Business Overview
Table 147. Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 149. Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 150. Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
Table 151. Guangdong Xinfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 152. Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 154. Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Andrographis Paniculana Injection Distributors List
Table 158. Andrographis Paniculana Injection Customers List
Table 159. Andrographis Paniculana Injection Market Trends
Table 160. Andrographis Paniculana Injection Market Drivers
Table 161. Andrographis Paniculana Injection Market Challenges
Table 162. Andrographis Paniculana Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographis Paniculana Injection
Figure 2. Global Andrographis Paniculana Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Andrographis Paniculana Injection Market Share by Type: 2025 & 2032
Figure 4. 2ml Product Picture
Figure 5. 5ml Product Picture
Figure 6. 10ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Andrographis Paniculana Injection Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Andrographis Paniculana Injection Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Andrographis Paniculana Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Andrographis Paniculana Injection Market Size (US$ Million), 2021–2032
Figure 15. Global Andrographis Paniculana Injection Sales (K Units), 2021–2032
Figure 16. Global Andrographis Paniculana Injection Average Price (US$/Unit), 2021–2032
Figure 17. Andrographis Paniculana Injection Report Years Considered
Figure 18. Andrographis Paniculana Injection Sales Share by Manufacturers in 2025
Figure 19. Global Andrographis Paniculana Injection Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Andrographis Paniculana Injection Players: Market Share by Revenue in Andrographis Paniculana Injection in 2025
Figure 21. Andrographis Paniculana Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Andrographis Paniculana Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 24. North America Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 25. United States Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 28. Europe Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 29. Germany Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Andrographis Paniculana Injection Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Andrographis Paniculana Injection Revenue Market Share by Region (2021–2032)
Figure 36. China Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 44. Latin America Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Andrographis Paniculana Injection by Type (2021–2032)
Figure 55. Global Revenue Market Share of Andrographis Paniculana Injection by Type (2021–2032)
Figure 56. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Andrographis Paniculana Injection by Application (2021–2032)
Figure 58. Global Revenue Market Share of Andrographis Paniculana Injection by Application (2021–2032)
Figure 59. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2021–2032)
Figure 60. Andrographis Paniculana Injection Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Andrographis Paniculana Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Andrographis Paniculana Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Andrographis Paniculana Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Andrographis Paniculana Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Andrographis Paniculana Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Andrographis Paniculana Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Andrographis Paniculana Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Andrographis Paniculana Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Andrographis Paniculana Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Andrographis Paniculana Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Andrographis Paniculana Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Andrographis Paniculana Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographis Paniculana Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Andrographis Paniculana Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographis Paniculana Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Andrographis Paniculana Injection Sales by Region (K Units), 2021–2026
Table 18. Global Andrographis Paniculana Injection Sales Market Share by Region (2021–2026)
Table 19. Global Andrographis Paniculana Injection Sales by Region (K Units), 2027–2032
Table 20. Global Andrographis Paniculana Injection Sales Market Share by Region (2027–2032)
Table 21. Global Andrographis Paniculana Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Andrographis Paniculana Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Andrographis Paniculana Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Andrographis Paniculana Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 27. North America Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 28. North America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Andrographis Paniculana Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Andrographis Paniculana Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Andrographis Paniculana Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Andrographis Paniculana Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Andrographis Paniculana Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Andrographis Paniculana Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Andrographis Paniculana Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Andrographis Paniculana Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Andrographis Paniculana Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Andrographis Paniculana Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Andrographis Paniculana Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Andrographis Paniculana Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Andrographis Paniculana Injection Sales Market Share by Type (2021–2026)
Table 53. Global Andrographis Paniculana Injection Sales Market Share by Type (2027–2032)
Table 54. Global Andrographis Paniculana Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Andrographis Paniculana Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Andrographis Paniculana Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Andrographis Paniculana Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Andrographis Paniculana Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Andrographis Paniculana Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Andrographis Paniculana Injection Sales Market Share by Application (2021–2026)
Table 63. Global Andrographis Paniculana Injection Sales Market Share by Application (2027–2032)
Table 64. Global Andrographis Paniculana Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Andrographis Paniculana Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Andrographis Paniculana Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Andrographis Paniculana Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
Table 71. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 74. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Shanxi Huawei Pharmaceutical Co., Ltd. Company Information
Table 76. Shanxi Huawei Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Shanxi Huawei Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 79. Shanxi Huawei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Company Information
Table 81. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 84. Zhengda Qingchunbao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Company Information
Table 86. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Description and Business Overview
Table 87. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Andrographis Paniculana Injection Product
Table 89. Changchun Dazheng Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
Table 90. Henan Kanghua Pharmaceutical Co., Ltd. Company Information
Table 91. Henan Kanghua Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Henan Kanghua Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 94. Henan Kanghua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Hainan Pharmaceutical Factory Co., Ltd. Company Information
Table 96. Hainan Pharmaceutical Factory Co., Ltd. Description and Business Overview
Table 97. Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hainan Pharmaceutical Factory Co., Ltd. Andrographis Paniculana Injection Product
Table 99. Hainan Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 100. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
Table 101. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 104. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information
Table 106. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 109. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
Table 111. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 114. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Lizhu Group Limin Pharmaceutical Factory Company Information
Table 116. Lizhu Group Limin Pharmaceutical Factory Description and Business Overview
Table 117. Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lizhu Group Limin Pharmaceutical Factory Andrographis Paniculana Injection Product
Table 119. Lizhu Group Limin Pharmaceutical Factory Recent Developments/Updates
Table 120. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Company Information
Table 121. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 124. Jiangsu Kangyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Company Information
Table 126. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 129. Jiangxi Yuankang Judu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Company Information
Table 131. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Description and Business Overview
Table 132. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Andrographis Paniculana Injection Product
Table 134. Shenwei Pharmaceutical (Sichuan) Co., Ltd. Recent Developments/Updates
Table 135. Shanxi Kangyi Pharmaceutical Co., Ltd. Company Information
Table 136. Shanxi Kangyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 137. Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Shanxi Kangyi Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 139. Shanxi Kangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 140. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Company Information
Table 141. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 144. Jiangsu Hengfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Guangdong Luofushan National Pharmaceutical Co., Ltd. Company Information
Table 146. Guangdong Luofushan National Pharmaceutical Co., Ltd. Description and Business Overview
Table 147. Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Guangdong Luofushan National Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 149. Guangdong Luofushan National Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 150. Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
Table 151. Guangdong Xinfeng Pharmaceutical Co., Ltd. Description and Business Overview
Table 152. Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Guangdong Xinfeng Pharmaceutical Co., Ltd. Andrographis Paniculana Injection Product
Table 154. Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Andrographis Paniculana Injection Distributors List
Table 158. Andrographis Paniculana Injection Customers List
Table 159. Andrographis Paniculana Injection Market Trends
Table 160. Andrographis Paniculana Injection Market Drivers
Table 161. Andrographis Paniculana Injection Market Challenges
Table 162. Andrographis Paniculana Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographis Paniculana Injection
Figure 2. Global Andrographis Paniculana Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Andrographis Paniculana Injection Market Share by Type: 2025 & 2032
Figure 4. 2ml Product Picture
Figure 5. 5ml Product Picture
Figure 6. 10ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Andrographis Paniculana Injection Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Andrographis Paniculana Injection Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Andrographis Paniculana Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Andrographis Paniculana Injection Market Size (US$ Million), 2021–2032
Figure 15. Global Andrographis Paniculana Injection Sales (K Units), 2021–2032
Figure 16. Global Andrographis Paniculana Injection Average Price (US$/Unit), 2021–2032
Figure 17. Andrographis Paniculana Injection Report Years Considered
Figure 18. Andrographis Paniculana Injection Sales Share by Manufacturers in 2025
Figure 19. Global Andrographis Paniculana Injection Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Andrographis Paniculana Injection Players: Market Share by Revenue in Andrographis Paniculana Injection in 2025
Figure 21. Andrographis Paniculana Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Andrographis Paniculana Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 24. North America Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 25. United States Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 28. Europe Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 29. Germany Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Andrographis Paniculana Injection Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Andrographis Paniculana Injection Revenue Market Share by Region (2021–2032)
Figure 36. China Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 44. Latin America Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Andrographis Paniculana Injection Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Andrographis Paniculana Injection Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Andrographis Paniculana Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Andrographis Paniculana Injection by Type (2021–2032)
Figure 55. Global Revenue Market Share of Andrographis Paniculana Injection by Type (2021–2032)
Figure 56. Global Andrographis Paniculana Injection Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Andrographis Paniculana Injection by Application (2021–2032)
Figure 58. Global Revenue Market Share of Andrographis Paniculana Injection by Application (2021–2032)
Figure 59. Global Andrographis Paniculana Injection Price (US$/Unit) by Application (2021–2032)
Figure 60. Andrographis Paniculana Injection Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232